BR9810311A - Fenóis alquil-4-silil heterocìclicos e tiofenóis úteis como agentes antioxidantes - Google Patents
Fenóis alquil-4-silil heterocìclicos e tiofenóis úteis como agentes antioxidantesInfo
- Publication number
- BR9810311A BR9810311A BR9810311-3A BR9810311A BR9810311A BR 9810311 A BR9810311 A BR 9810311A BR 9810311 A BR9810311 A BR 9810311A BR 9810311 A BR9810311 A BR 9810311A
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- useful
- hydrogen
- integer
- oxide
- Prior art date
Links
- 239000003963 antioxidant agent Substances 0.000 title abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 abstract 1
- 102000015271 Intercellular Adhesion Molecule-1 Human genes 0.000 abstract 1
- 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 abstract 1
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 208000037976 chronic inflammation Diseases 0.000 abstract 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000006866 deterioration Effects 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 230000003859 lipid peroxidation Effects 0.000 abstract 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
- 239000011368 organic material Substances 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 150000002989 phenols Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
- C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Patentes de Invenção: <B>"FENóIS ALQUIL-4-SILIL HETEROCìCLICOS E TIOFENóIS úTEIS COMO AGENTES ANTIOXIDANTES"<D>. A presente invenção provê compostos da fórmula onde R é hidrogênio ou -C(O)-(CH~ 2~)~ m~-Q onde Q é hidrogênio ou -COOH e m é um número inteiro 1, 2, 3 ou 4; R~ 1~, R~ 5~ e R~ 6~ são independentemente um grupo C~ 1~-C~ 6~alquila; R~ 2~, R~ 3~ e R~ 4~ são independentemente hidrogênio ou um grupo C~ 1~-C~ 6~ alquila; Z é um grupo tio, óxi ou metileno; A é um grupo C~ 1~-C~ 4~ alquileno; X é tio ou óxi; e G~ 1~ e G~ 2~ são independentemente hidrogênio, C~ 1~-C~ 6~alquila ou -C(O)-(CH~ 2~)~ n~-CH~ 3~ e n é um número inteiro 0, 1, 2 ou 3; ou um seu sal farmaceuticamente aceitável; úteis para o tratamento da aterosclerose ou distúrbios inflamatórios crónicos; para a inibição da expressão da VCAM-1 e/ou ICAm-1 induzida por citocina; para a inibição da peroxidação de lipídio LDL; para a diminuição do colesterol no plasma; e como aditivos químicos antioxidantes úteis para prevenir a deterioração oxidativa em materiais orgânicos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88162797A | 1997-06-24 | 1997-06-24 | |
| PCT/US1998/010510 WO1998058938A1 (en) | 1997-06-24 | 1998-05-21 | Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9810311A true BR9810311A (pt) | 2000-09-19 |
Family
ID=25378856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9810311-3A BR9810311A (pt) | 1997-06-24 | 1998-05-21 | Fenóis alquil-4-silil heterocìclicos e tiofenóis úteis como agentes antioxidantes |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0998477B1 (pt) |
| JP (1) | JP2002514226A (pt) |
| KR (1) | KR20010014118A (pt) |
| CN (1) | CN1147495C (pt) |
| AR (1) | AR013114A1 (pt) |
| AT (1) | ATE235498T1 (pt) |
| AU (1) | AU731278B2 (pt) |
| BR (1) | BR9810311A (pt) |
| CA (1) | CA2293461C (pt) |
| DE (1) | DE69812635T2 (pt) |
| DK (1) | DK0998477T3 (pt) |
| ES (1) | ES2190592T3 (pt) |
| HU (1) | HUP0002775A3 (pt) |
| IL (1) | IL133598A (pt) |
| NO (1) | NO996395L (pt) |
| NZ (1) | NZ501342A (pt) |
| PT (1) | PT998477E (pt) |
| SI (1) | SI0998477T1 (pt) |
| TW (1) | TW517054B (pt) |
| WO (1) | WO1998058938A1 (pt) |
| ZA (1) | ZA985318B (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007509054A (ja) * | 2003-10-17 | 2007-04-12 | アミリン・ファーマシューティカルズ，インコーポレイテッド | 血管健康を促進するシリルフェノール |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5155250A (en) * | 1990-07-05 | 1992-10-13 | Merrell Dow Pharmaceuticals Inc. | 2,6-di-alkyl-4-silyl-phenols as antiatheroscerotic agents |
| EP1468693A3 (en) * | 1993-12-10 | 2004-11-03 | Merrell Pharmaceuticals Inc. | Use of 2,6-di -alkyl-4-silyl-phenols for treating diabetes mellitus |
-
1998
- 1998-05-21 CN CNB988065770A patent/CN1147495C/zh not_active Expired - Fee Related
- 1998-05-21 BR BR9810311-3A patent/BR9810311A/pt not_active IP Right Cessation
- 1998-05-21 CA CA002293461A patent/CA2293461C/en not_active Expired - Fee Related
- 1998-05-21 ES ES98923681T patent/ES2190592T3/es not_active Expired - Lifetime
- 1998-05-21 WO PCT/US1998/010510 patent/WO1998058938A1/en not_active Ceased
- 1998-05-21 DE DE69812635T patent/DE69812635T2/de not_active Expired - Fee Related
- 1998-05-21 AU AU75915/98A patent/AU731278B2/en not_active Ceased
- 1998-05-21 JP JP50443199A patent/JP2002514226A/ja active Pending
- 1998-05-21 PT PT98923681T patent/PT998477E/pt unknown
- 1998-05-21 HU HU0002775A patent/HUP0002775A3/hu unknown
- 1998-05-21 AT AT98923681T patent/ATE235498T1/de not_active IP Right Cessation
- 1998-05-21 KR KR19997012174A patent/KR20010014118A/ko not_active Abandoned
- 1998-05-21 IL IL13359898A patent/IL133598A/en not_active IP Right Cessation
- 1998-05-21 DK DK98923681T patent/DK0998477T3/da active
- 1998-05-21 EP EP98923681A patent/EP0998477B1/en not_active Expired - Lifetime
- 1998-05-21 NZ NZ501342A patent/NZ501342A/en unknown
- 1998-05-21 SI SI9830429T patent/SI0998477T1/xx unknown
- 1998-06-18 ZA ZA985318A patent/ZA985318B/xx unknown
- 1998-06-19 TW TW087109867A patent/TW517054B/zh not_active IP Right Cessation
- 1998-06-22 AR ARP980102977A patent/AR013114A1/es not_active Application Discontinuation
-
1999
- 1999-12-22 NO NO996395A patent/NO996395L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1027815A1 (en) | 2001-01-23 |
| DE69812635D1 (de) | 2003-04-30 |
| DK0998477T3 (da) | 2003-07-21 |
| IL133598A (en) | 2004-08-31 |
| ATE235498T1 (de) | 2003-04-15 |
| CA2293461C (en) | 2004-02-24 |
| HUP0002775A3 (en) | 2001-08-28 |
| KR20010014118A (ko) | 2001-02-26 |
| EP0998477A1 (en) | 2000-05-10 |
| CN1261367A (zh) | 2000-07-26 |
| IL133598A0 (en) | 2001-04-30 |
| AU731278B2 (en) | 2001-03-29 |
| DE69812635T2 (de) | 2003-10-23 |
| HUP0002775A2 (hu) | 2001-05-28 |
| ZA985318B (en) | 1999-01-11 |
| NO996395L (no) | 2000-02-23 |
| EP0998477B1 (en) | 2003-03-26 |
| AU7591598A (en) | 1999-01-04 |
| NO996395D0 (no) | 1999-12-22 |
| AR013114A1 (es) | 2000-12-13 |
| SI0998477T1 (en) | 2003-08-31 |
| WO1998058938A1 (en) | 1998-12-30 |
| JP2002514226A (ja) | 2002-05-14 |
| NZ501342A (en) | 2001-10-26 |
| CA2293461A1 (en) | 1998-12-30 |
| PT998477E (pt) | 2003-07-31 |
| ES2190592T3 (es) | 2003-08-01 |
| TW517054B (en) | 2003-01-11 |
| CN1147495C (zh) | 2004-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9909961A (pt) | Derivados de cadeia lateral alquila e alquenila funcionalizados de glicinamidas como inibidores de farnesil transferase | |
| Mitra et al. | Oxidative DNA cleavage by the antitumor antibiotic leinamycin and simple 1, 2-dithiolan-3-one 1-oxides: Evidence for thiol-dependent conversion of molecular oxygen to DNA-cleaving oxygen radicals mediated by polysulfides | |
| BR9913138A (pt) | Derivados de quinolin-2-ona substituìdos com alquinila úteis como agentes contra o câncer | |
| BR0111599A (pt) | Inibidores de hmg-coa redutase e método | |
| BR9807339A (pt) | Derivados 3-piperidil-4-oxoquinazolina e composições farmacêuticas compreendendo os mesmos. | |
| BR9713372A (pt) | Fenóis e tiofenóis substituìdos úteis como agentes antioxidantes | |
| CA2251991A1 (en) | Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents | |
| ATE283266T1 (de) | 1,5-benzothiazepine und ihre verwendungs als hypolipidämika | |
| AU4120699A (en) | Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress | |
| EP1334719A3 (en) | Pentafluorobenzenesulfonamides and analogs | |
| BR0005633A (pt) | Derivados de quinolina úteis para inibição da farnesil proteìna transferase | |
| ES2137169T3 (es) | Nuevos derivados de tiazolilbenzofurano, procedimientos para su preparacion y composicion farmaceutica que los contiene. | |
| IL175398A0 (en) | Steroidal compounds and pharmaceutical compositions containing them for treating oxidative stress and inflammation | |
| KR960013370A (ko) | 트리글리세리드 과다 방지 조성물 | |
| FR2676444B1 (fr) | Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant. | |
| BR9608502A (pt) | Derivado da pirrola e composição medicinal | |
| BR9905089A (pt) | Derivados macrolìdeos | |
| AU1146992A (en) | New acylaminophenol compounds, process for their preparation and pharmaceutical compositions containing them | |
| BR9810311A (pt) | Fenóis alquil-4-silil heterocìclicos e tiofenóis úteis como agentes antioxidantes | |
| CA2046050A1 (en) | Bis[4-(2,6-di-alkyl)phenol]silane derivatives as antiatherosclerotic agents | |
| BR9910206A (pt) | Derivados de higromicina a. | |
| EA200000389A3 (ru) | Новые замещенные пиридины или пиперидины, способ их получения и содержащие их фармацевтические композиции | |
| DE69200665D1 (de) | Lipoxygenase inhibierende Hydroxamsäure und N-Hydroxyharnstoff-Derivate. | |
| PT966462E (pt) | Compostos heterociclicos uteis como inibidores da ciclase do oxido-esqualeno | |
| PT819112E (pt) | Processo oxidativo para a preparacao de derivados da narvedina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 4A, 5A, 6A, 7A, 8A E 9A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1889 DE 20/03/2007. |